Lee Johnson Capital Management’s Merck MRK Stock Holding History

Lee Johnson Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,082	Closed	-$1.21M	–	92
2026 Q1	$1.21M	Buy	+10,082	New	+$1.16M	0.43%	37

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lee Johnson Capital Management's MRK Position: Q2 2026 in Review

Lee Johnson Capital Management sold out of Merck (MRK) in Q2 2026, closing a stake of 10,082 shares — an estimated $1.21M sold.

Lee Johnson Capital Management first reported a position in MRK in Q1 2026 and held it in 1 quarter. The position peaked at $1.21M in Q1 2026. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Lee Johnson Capital Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
Lee Johnson Capital Management sold 10,082 Merck shares in Q2 2026, an estimated $1.21M.
Lee Johnson Capital Management first reported a position in Merck in Q1 2026 and held it in 1 quarter.
Lee Johnson Capital Management's Merck position peaked at $1.21M in Q1 2026.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Lee Johnson Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.